Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Cooper

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|September 25, 1999
White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD])H A Cooper, D V Exner, M A Waclawiw, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1981
The multimeric distribution of factor VIII-related antigen studied by an improved crossed-immunoelectrophoresis techniqueM A Lamb, H M Reisner, H A Cooper, et al.
American Journal of Diseases of Children (1960)|April 1, 1971
Hydrocephalus in child with von Willebrand's disease. Treatment by ventriculoperitoneal shuntH A Cooper, D J Bowie, E O Burgert, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Proteolysis of human fixed, washed platelets by gram-negative bacterial metalloproteases: effect on von Willebrand factor-human platelet interactionsH A Cooper, W P Bennett, A Kreger, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1981
The effect of extracellular proteases from gran-negative bacteria on the interaction of von Willebrand factor with human plateletsH A Cooper, W P Bennett, A Kreger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic proceduresH A Cooper, C P Jones, E Campion, et al.
Thrombosis Et Diathesis Haemorrhagica. Supplementum|January 1, 1973
The diagnosis of intravascular coagulationE J Bowie, H A Cooper, V Fuster, et al.
The New England Journal of Medicine|April 9, 1981
A naturally occurring antibody that inhibits fibrin polymerizationW K Hoots, N A Carrell, R H Wagner, et al.
Thrombosis Research|March 1, 1975
Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation testK M Brinkhous, J E Graham, H A Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1973
Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand FactorsT R Griggs, H A Cooper, W P Webster, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|September 25, 1999
White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD])H A Cooper, D V Exner, M A Waclawiw, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1981
The multimeric distribution of factor VIII-related antigen studied by an improved crossed-immunoelectrophoresis techniqueM A Lamb, H M Reisner, H A Cooper, et al.
American Journal of Diseases of Children (1960)|April 1, 1971
Hydrocephalus in child with von Willebrand's disease. Treatment by ventriculoperitoneal shuntH A Cooper, D J Bowie, E O Burgert, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Proteolysis of human fixed, washed platelets by gram-negative bacterial metalloproteases: effect on von Willebrand factor-human platelet interactionsH A Cooper, W P Bennett, A Kreger, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1981
The effect of extracellular proteases from gran-negative bacteria on the interaction of von Willebrand factor with human plateletsH A Cooper, W P Bennett, A Kreger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic proceduresH A Cooper, C P Jones, E Campion, et al.
Thrombosis Et Diathesis Haemorrhagica. Supplementum|January 1, 1973
The diagnosis of intravascular coagulationE J Bowie, H A Cooper, V Fuster, et al.
The New England Journal of Medicine|April 9, 1981
A naturally occurring antibody that inhibits fibrin polymerizationW K Hoots, N A Carrell, R H Wagner, et al.
Thrombosis Research|March 1, 1975
Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation testK M Brinkhous, J E Graham, H A Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1973
Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand FactorsT R Griggs, H A Cooper, W P Webster, et al.
Pageof 6